Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $8.8200 (-4.85%) ($8.8200 - $8.8200) on Mon. Jan. 11, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.6% (three month average) | RSI | 58 | Latest Price | $8.8200(-4.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -1.2% a day on average for past five trading days. | Weekly Trend | AUTL advances 1.9% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) LIT(14%) SKYY(13%) XBI(13%) ARKG(12%) BLOK(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.3% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) IGOV(-6%) UNG(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.3% (StdDev 4.6%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $8.83 | 5 Day Moving Average | $9.07(-2.76%) | 10 Day Moving Average | $9.03(-2.33%) | 20 Day Moving Average | $8.83(-0.11%) | To recent high | -31% | To recent low | 8.1% | Market Cap | $461m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |